Literature DB >> 26444767

White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.

Jean-Philippe Coutu1,2, Alison Goldblatt1,3, H Diana Rosas1,4, David H Salat1,3,5.   

Abstract

White matter lesions are highly prevalent in individuals with Alzheimer's disease (AD). Although these lesions are presumed to be of vascular origin and linked to small vessel disease in older adults, little information exists about their relationship to markers of classical AD neurodegeneration. Thus, we examined the link between these white matter changes (WMC) segmented on T1-weighted MRI and imaging markers presumed to be altered due to primary AD neurodegenerative processes. Tissue microstructure of WMC was quantified using diffusion tensor imaging and the relationship of WMC properties and volume to neuroimaging markers was examined in 219 cognitively healthy older adults and individuals with mild cognitive impairment and AD using data from the Alzheimer's Disease Neuroimaging Initiative. No significant group differences in WMC properties were found. However, there were strong associations between diffusivity of WMC and ventricular volume, volume of WMC and total WM volume. In comparison, group differences in parahippocampal white matter microstructure were found for all diffusion metrics and were largely explained by hippocampal volume. Factor analysis on neuroimaging markers suggested two independent sets of covarying degenerative changes, with potentially age- and vascular-mediated tissue damage contributing to one factor and classical neurodegenerative changes associated with AD contributing to a second factor. These data demonstrate two potentially distinct classes of degenerative change in AD, with one factor strongly linked to aging, ventricular expansion, and both volume and tissue properties of white matter lesions, while the other factor related to classical patterns of cortical and hippocampal neurodegeneration in AD.

Entities:  

Keywords:  Alzheimer’s disease; cerebral ventricles; diffusion tensor imaging; hippocampus; leukoaraiosis; mild cognitive impairment; white matter

Mesh:

Year:  2016        PMID: 26444767      PMCID: PMC5996384          DOI: 10.3233/JAD-150306

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  59 in total

1.  Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Authors:  Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

2.  Vascular burden and Alzheimer disease pathologic progression.

Authors:  Raymond Y Lo; William J Jagust
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

4.  White matter pathology isolates the hippocampal formation in Alzheimer's disease.

Authors:  D H Salat; D S Tuch; A J W van der Kouwe; D N Greve; V Pappu; S Y Lee; N D Hevelone; A K Zaleta; J H Growdon; S Corkin; B Fischl; H D Rosas
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

5.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Authors:  C DeCarli; D Mungas; D Harvey; B Reed; M Weiner; H Chui; W Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

6.  Accurate and robust brain image alignment using boundary-based registration.

Authors:  Douglas N Greve; Bruce Fischl
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

7.  White matter microstructure in relation to education in aging and Alzheimer's disease.

Authors:  Stefan J Teipel; Thomas Meindl; Maximilian Wagner; Thomas Kohl; Katharina Bürger; Maximilian F Reiser; Sabine Herpertz; Hans-Jürgen Möller; Harald Hampel
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12

9.  Non-Gaussian water diffusion in aging white matter.

Authors:  Jean-Philippe Coutu; J Jean Chen; H Diana Rosas; David H Salat
Journal:  Neurobiol Aging       Date:  2013-12-04       Impact factor: 4.673

10.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  15 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

2.  Factors influencing accuracy of cortical thickness in the diagnosis of Alzheimer's disease.

Authors:  Mahanand Belathur Suresh; Bruce Fischl; David H Salat
Journal:  Hum Brain Mapp       Date:  2017-12-21       Impact factor: 5.038

3.  Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Authors:  Xiuming Zhang; Elizabeth C Mormino; Nanbo Sun; Reisa A Sperling; Mert R Sabuncu; B T Thomas Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

4.  Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.

Authors:  Theresa M Harrison; Anne Maass; Suzanne L Baker; William J Jagust
Journal:  Neurobiol Aging       Date:  2018-03-27       Impact factor: 4.673

5.  Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.

Authors:  Chan-Mi Kim; Rachel L Alvarado; Kimberly Stephens; Hsiao-Ying Wey; Dany J J Wang; Elizabeth C Leritz; David H Salat
Journal:  Neurobiol Aging       Date:  2019-11-06       Impact factor: 4.673

6.  Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease.

Authors:  Emily R Lindemer; Douglas N Greve; Bruce Fischl; Jean C Augustinack; David H Salat
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Dose-response association between plasma homocysteine and white matter lesions in patients with hypertension: a case-control study.

Authors:  Yujuan Yuan; Xintian Cai; Yan Liu; Nanfang Li
Journal:  Hypertens Res       Date:  2022-08-23       Impact factor: 5.528

8.  Oxygen extraction efficiency and white matter lesion burden in older adults exhibiting radiological evidence of capillary shunting.

Authors:  Meher R Juttukonda; Kimberly A Stephens; Yi-Fen Yen; Casey M Howard; Jonathan R Polimeni; Bruce R Rosen; David H Salat
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-08       Impact factor: 6.960

9.  Two distinct classes of degenerative change are independently linked to clinical progression in mild cognitive impairment.

Authors:  Jean-Philippe Coutu; Emily R Lindemer; Ender Konukoglu; David H Salat
Journal:  Neurobiol Aging       Date:  2017-02-16       Impact factor: 4.673

Review 10.  Resumption of Anticoagulation After Intracranial Hemorrhage.

Authors:  Ivan Rocha Ferreira da Silva; Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.